Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Revenue

Cardiff Oncology had revenue of $610.00K in the twelve months ending March 31, 2024, with 54.43% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $205.00K with 146.99% year-over-year growth. In the year 2023, Cardiff Oncology had annual revenue of $488.00K with 26.42% growth.

• Revenue (ttm): $610.00K
• Revenue Growth: +54.43%
• P/S Ratio: 328.36
• Revenue / Employee: $19,677
• Employees: 31
• Market Cap: 200.30M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	488.00K	102.00K	26.42%
Dec 31, 2022	386.00K	27.00K	7.52%
Dec 31, 2021	359.00K	-7.00K	-1.91%
Dec 31, 2020	366.00K	121.37K	49.61%
Dec 31, 2019	244.63K	-133.69K	-35.34%
Dec 31, 2018	378.33K	-127.08K	-25.14%
Dec 31, 2017	505.40K	124.33K	32.63%
Dec 31, 2016	381.07K	68.26K	21.82%
Dec 31, 2015	312.81K	32.63K	11.65%
Dec 31, 2014	280.18K	20.93K	8.07%
Dec 31, 2013	259.25K	-191.16K	-42.44%
Dec 31, 2012	450.40K	192.71K	74.78%
Dec 31, 2011	257.70K	-7.97K	-3.00%
Dec 31, 2010	265.67K	-388.33K	-59.38%
Dec 31, 2009	653.99K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.